Menu

• Ask a Health Expert about CEREBELLAR ATROPHY
• Post Your Side Effect related to CEREBELLAR ATROPHY
• CEREBELLAR ATROPHY and FDA Warnings
• CEREBELLAR ATROPHY in Patients Wiki
• Report CEREBELLAR ATROPHY in Drug Side Effect Survey

CEREBELLAR ATROPHY side effect

What is CEREBELLAR ATROPHY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Cipramil Side Effects Report #5532167-6
Health Professional from DENMARK reported CIPRAMIL problem on Nov 12, 2007. Female patient, 69 years of age, was diagnosed with depression, major depression, psychotic disorder and was treated with CIPRAMIL. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, cerebral atrophy, depression, fear, microangiopathy, parkinsonism, psychotic disorder, . CIPRAMIL dosage: 20 MG QD PO. During the same period patient was treated with SEROQUEL, MADOPAR. Patient was hospitalized. Patient recovered.

Phenytoin Side Effects Report #5534318-6
PHENYTOIN problem was reported by a Consumer or non-health professional from HONG KONG on Nov 14, 2007. Female patient, 31 years of age, was diagnosed with epilepsy and was treated with PHENYTOIN. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, convulsion, head injury, skull malformation, . PHENYTOIN dosage: unknown. During the same period patient was treated with VALPROATE, PREGABALIN, CLOBAZAM. Patient was hospitalized. Patient recovered.

Fabrazyme Side Effects Report #5480917-X
Health Professional from UNITED KINGDOM reported FABRAZYME problem on Sept 21, 2007. Female patient was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, spinal cord infarction, . FABRAZYME dosage: 1 MG/KG Q2WKS IV. Patient recovered.

Lamivudine Side Effects Report #5379496-7
LAMIVUDINE problem was reported by a Health Professional from UNITED STATES on June 18, 2007. Female patient, 37 years of age, was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, condition aggravated, dysarthria, immune reconstitution syndrome, nervous system disorder, . LAMIVUDINE dosage: unknown. During the same period patient was treated with NEVIRAPINE, ZIDOVUDINE. Patient recovered.


Lamivudine Side Effects Report #5379496-7
Health Professional from UNITED STATES reported LAMIVUDINE problem on June 18, 2007. Female patient, 37 years of age, was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, condition aggravated, dysarthria, immune reconstitution syndrome, nervous system disorder, . LAMIVUDINE dosage: unknown. During the same period patient was treated with NEVIRAPINE, ZIDOVUDINE. Patient recovered.

Docetaxel Side Effects Report #5714677-1
DOCETAXEL problem was reported by a Health Professional from UNITED STATES on Apr 16, 2008. Male patient, 76 years of age, weighting 162.0 lb, was diagnosed with prostate cancer and was treated with DOCETAXEL. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, cerebral atrophy, cerebral ischaemia, fatigue, mental status changes, neutropenia, . DOCETAXEL dosage: DOSE: 710 MG AS CUMULATIVE DOSE. During the same period patient was treated with MONOCLONAL ANTIBODIES, CELEBREX, COMPAZINE, DECADRON, DETROL, EFFEXOR, SERTACONAZOLE NITRATE, TAMSULOSIN. Patient was hospitalized. Patient recovered.

Lamivudine Side Effects Report #5345250-5
Consumer or non-health professional from UNITED STATES reported LAMIVUDINE problem on May 22, 2007. Female patient, 37 years of age, was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, csf test abnormal, dysarthria, gait disturbance, immune reconstitution syndrome, nuclear magnetic resonance imaging brain abnormal, . LAMIVUDINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, NEVIRAPINE. Patient recovered.

Baclofen Side Effects Report #5371472-3
BACLOFEN problem was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2007. Female patient, 48 years of age, was treated with BACLOFEN. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, cerebrovascular accident, grand mal convulsion, pneumonia, unresponsive to stimuli, . BACLOFEN dosage: 30 MG (10 MG, 3 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.

Lithium Side Effects Report #5316208-7
Consumer or non-health professional from reported LITHIUM CARBONATE problem on Apr 25, 2007. Female patient, 52 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM CARBONATE. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, renal failure acute, therapeutic agent toxicity, . LITHIUM CARBONATE dosage: unknown. Patient was hospitalized. Patient recovered.


Lithium Side Effects Report #5316209-9
LITHIUM CARBONATE problem was reported by a Consumer or non-health professional from on Apr 25, 2007. Female patient, 44 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM CARBONATE. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, erythema multiforme, renal failure acute, therapeutic agent toxicity, . LITHIUM CARBONATE dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, PERPHENAZINE. Patient was hospitalized. Patient recovered.

Lithium Side Effects Report #5316210-5
Consumer or non-health professional from reported LITHIUM CARBONATE problem on Apr 25, 2007. Male patient, 57 years of age, was diagnosed with bipolar disorder and was treated with LITHIUM CARBONATE. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, renal failure acute, therapeutic agent toxicity, . LITHIUM CARBONATE dosage: unknown. During the same period patient was treated with QUETIAPINE FUMARATE, PAROXETINE, VALPROIC ACID, PROPRANOLOL. Patient was hospitalized. Patient recovered.

Coumadin Side Effects Report #5321077-5
COUMADIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 08, 2007. Female patient, weighting 119.0 lb, was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, cerebral atrophy, . COUMADIN dosage: unknown. During the same period patient was treated with LOVASTATIN, METOPROLOL SUCCINATE, HYZAAR, DIGITEK, POTASSIUM ACETATE, OMEPRAZOLE, PREMARIN. Patient recovered.

Phenytoin Side Effects Report #5324214-1
Consumer or non-health professional from HONG KONG reported PHENYTOIN problem on Apr 26, 2007. Female patient, 31 years of age, was diagnosed with epilepsy and was treated with PHENYTOIN. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, convulsion, exostosis, head injury, . PHENYTOIN dosage: unknown. During the same period patient was treated with VALPROIC ACID, PREGABALIN, CLOBAZAM. Patient recovered.

Baclofen Side Effects Report #5303046-4
BACLOFEN problem was reported by a Health Professional from UNITED STATES on Apr 12, 2007. Female patient, 48 years of age, was treated with BACLOFEN. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, cerebrovascular accident, grand mal convulsion, intubation, moaning, pneumonia, unresponsive to stimuli, . BACLOFEN dosage: 10 MG TID. During the same period patient was treated with OXYBUTON, GABAPENTIN, MONTELUKAST, HYDROCHLOROTHIAZIDE W, ASPIRIN, OMEPRAZOLE, ATORVASTATIN CALCIUM, SERTRALINE. Patient was hospitalized. Patient recovered.


Ritonavir Side Effects Report #5306305-4
Consumer or non-health professional from reported RITONAVIR SOFT GELATIN CAPSULES problem on Apr 20, 2007. Male patient, weighting 249.1 lb, was diagnosed with hiv infection, depression, anaemia, tinea pedis and was treated with RITONAVIR SOFT GELATIN CAPSULES. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, cerebral atrophy, cerebral ischaemia, disorientation, partial seizures, transient ischaemic attack, . RITONAVIR SOFT GELATIN CAPSULES dosage: unknown. During the same period patient was treated with VIREAD, LAMIVUDINE, BUSPIRONE, CITALOPRAM HYDROBROMIDE, EPOETIN ALFA, SPECTRAZOLE. Patient recovered.

Singulair Side Effects Report #5345052-X
SINGULAIR problem was reported by a Physician from UNITED STATES on Oct 03, 2006. Male patient, child 4 years of age, weighting 34.00 lb, was diagnosed with rhinitis allergic and was treated with SINGULAIR. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, cerebral cyst, convulsion, nervous system disorder, . SINGULAIR dosage: 4 MG/DAILY/PO. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5657652-8
Consumer or non-health professional from FRANCE reported PROGRAF problem on Feb 25, 2008. Male patient, 57 years of age, was diagnosed with renal transplant, atrial fibrillation and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: autonomic nervous system imbalance, cerebellar atrophy, cerebellar syndrome, cytomegalovirus infection, gait disturbance, . PROGRAF dosage: unknown. During the same period patient was treated with MYFORTIC, RAPAMUNE, PREVISCAN, CORTANCYL, NEORAL. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5663444-6
PROGRAF problem was reported by a Health Professional from FRANCE on Feb 22, 2008. Male patient, 57 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: autonomic nervous system imbalance, cerebellar atrophy, . PROGRAF dosage: unknown. During the same period patient was treated with NEORAL, MYFORTIC, RAPAMUNE, PREVISCAN, PREDNISONE. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5679938-3
Health Professional from FRANCE reported PROGRAF problem on Mar 06, 2008. Male patient, 57 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: autonomic nervous system imbalance, cerebellar atrophy, cerebellar syndrome, . PROGRAF dosage: unknown. During the same period patient was treated with NEORAL, MYFORTIC, RAPAMUNE, PREVISCAN, PREDNISONE. Patient was hospitalized. Patient recovered.


Ortho Side Effects Report #5622018-3
ORTHO EVRA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 01, 2008. Female patient, weighting 162.0 lb, was diagnosed with contraception, dizziness, headache and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: artery dissection, cerebellar atrophy, cerebellar infarction, cerebral infarction, cerebrovascular accident, . ORTHO EVRA dosage: unknown. During the same period patient was treated with NYQUIL, MECLIZINE, ADVIL. Patient was hospitalized. Patient recovered.

Valproic Side Effects Report #5586932-X
Health Professional from UNITED KINGDOM reported VALPROIC ACID problem on Jan 07, 2008. Female patient, 43 years of age, was diagnosed with affective disorder, schizophrenia and was treated with VALPROIC ACID. After drug was administered, patient experienced the following problems/side effects: balance disorder, cerebellar atrophy, confusional state, dysarthria, menstrual disorder, sedation, toxic encephalopathy, . VALPROIC ACID dosage: unknown. During the same period patient was treated with CLOZAPINE, LITHIUM CARBONATE. Patient recovered.

Adartrel Side Effects Report #5554301-4
ADARTREL problem was reported by a Physician from GERMANY on Dec 04, 2007. Female patient was treated with ADARTREL. After drug was administered, patient experienced the following problems/side effects: arterial disorder, cerebellar atrophy, cerebral atrophy, cerebral microangiopathy, chest discomfort, circulatory collapse, headache, herpes zoster, hyponatraemia, . ADARTREL dosage: 1.5MG PER DAY. During the same period patient was treated with SIFROL, PLAVIX, LORZAAR, RESTEX. Patient was hospitalized. Patient recovered.

Citalopram Side Effects Report #5582902-6
Health Professional from GERMANY reported CITALOPRAM HYDROBROMIDE problem on Dec 17, 2007. Female patient, 69 years of age, was diagnosed with depression, major depression, psychotic disorder and was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, cerebellar atrophy, cerebral atrophy, major depression, microangiopathy, parkinsonism, psychotic disorder, . CITALOPRAM HYDROBROMIDE dosage: 20 MG QD PO. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, SEROQUEL, MADOPAR. Patient was hospitalized. Patient recovered.

Atropine Side Effects Report #5447781-6
ATROPINE SULPHATE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 27, 2007. Male patient, 62 years of age, was diagnosed with preoperative care and was treated with ATROPINE SULPHATE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, cerebellar atrophy, cerebral atrophy, contusion, convulsion, encephalitis toxic, fall, psychotic disorder, sensory disturbance, . ATROPINE SULPHATE dosage: unknown. During the same period patient was treated with BETA BLOCKING AGENTS, OXYCONTIN, ACYCLOVIR, ERGOCALCIFEROL, ESOMEPRAZOLE MAGNESIUM, FLUCONAZOLE, HYDROCORTISONE, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Carboplatin Side Effects Report #5460770-0
Consumer or non-health professional from FRANCE reported CARBOPLATIN problem on Sept 03, 2007. Male patient, 82 years of age, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, cerebellar atrophy, cerebral atrophy, cerebral ischaemia, convulsion, . CARBOPLATIN dosage: unknown. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.

Betaseron Side Effects Report #5409010-9
BETASERON problem was reported by a Health Professional from UNITED STATES on July 24, 2007. Female patient, 64 years of age, weighting 230.0 lb, was diagnosed with secondary progressive multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: arthritis, cerebellar atrophy, cerebral atrophy, intervertebral disc disorder, intervertebral disc protrusion, musculoskeletal stiffness, spinal osteoarthritis, . BETASERON dosage: unknown. During the same period patient was treated with SYNTHROID, DETROL, CORTICOSTEROIDS. Patient was hospitalized. Patient recovered.

Carboplatin Side Effects Report #5411276-6
Consumer or non-health professional from FRANCE reported CARBOPLATIN problem on July 23, 2007. Male patient, 82 years of age, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, cerebellar atrophy, cerebral atrophy, cerebral ischaemia, convulsion, . CARBOPLATIN dosage: unknown. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.

Taxol Side Effects Report #5389347-2
TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2007. Female patient, weighting 299.8 lb, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: balance disorder, cerebellar atrophy, cerebral atrophy, fall, head injury, skin laceration, vertigo, . TAXOL dosage: 335 MG. Patient was hospitalized. Patient recovered.

Taxol Side Effects Report #5389347-2
Consumer or non-health professional from UNITED STATES reported TAXOL problem on July 13, 2007. Female patient, weighting 299.8 lb, was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: balance disorder, cerebellar atrophy, cerebral atrophy, fall, head injury, skin laceration, vertigo, . TAXOL dosage: 335 MG. Patient was hospitalized. Patient recovered.

Ritonavir Side Effects Report #5713020-1
RITONAVIR SOFT GELATIN CAPSULES problem was reported by a Consumer or non-health professional from AUSTRALIA on Apr 16, 2008. Male patient, weighting 222.7 lb, was diagnosed with hiv infection, prophylaxis, blood prolactin increased, herpes simplex and was treated with RITONAVIR SOFT GELATIN CAPSULES. After drug was administered, patient experienced the following problems/side effects: brain stem haemorrhage, cerebellar atrophy, . RITONAVIR SOFT GELATIN CAPSULES dosage: unknown. During the same period patient was treated with PREZISTA, ABACAVIR, TENOFOVIR DISOPROXIL FUMARATE, LAMIVUDINE, ABACAVIR SULPHATE, ACETYLSALICYLIC ACID SRT, CABERGOLINE, VALACYCLOVIR. Patient recovered.

Theophylline Side Effects Report #5343613-5
Consumer or non-health professional from JAPAN reported THEOPHYLLINE problem on May 21, 2007. Female patient, child 4 years of age, was diagnosed with asthma and was treated with THEOPHYLLINE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, cerebellar atrophy, csf test abnormal, electroencephalogram abnormal, encephalopathy, hyperammonaemia, hyperglycaemia, hyperpyrexia, interleukin level increased, . THEOPHYLLINE dosage: unknown. Patient was hospitalized. Patient recovered.

Prednisone Side Effects Report #5484847-9
PREDNISONE problem was reported by a Physician from UNITED KINGDOM on Sept 25, 2007. Male patient, 41 years of age, was diagnosed with systemic lupus erythematosus and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: arachnoid cyst, central nervous system necrosis, cerebellar atrophy, collapse of lung, coordination abnormal, facial palsy, jc virus infection, lymphopenia, mean cell volume increased, . PREDNISONE dosage: 15 MG;QD. During the same period patient was treated with AZATHIOPRINE, ORAPRED. Patient died.

Keppra Side Effects Report #5429783-9
Pharmacist from UNITED STATES reported KEPPRA problem on Aug 10, 2007. Male patient, 44 years of age, weighting 121.7 lb, was diagnosed with complex partial seizures and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: anaemia, calcinosis, cerebellar atrophy, cerebral atrophy, convulsion, myelopathy, . KEPPRA dosage: 1000 MG 2/D IV. During the same period patient was treated with DILANTIN. Patient recovered.

Depocyt Side Effects Report #5741413-5
DEPOCYT problem was reported by a Physician from POLAND on May 02, 2008. Female patient, 22 years of age, weighting 99.21 lb, was diagnosed with acute lymphocytic leukaemia and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: acute lymphocytic leukaemia, balance disorder, cerebellar atrophy, cerebral atrophy, dizziness, facial paresis, headache, infection, loss of consciousness, . DEPOCYT dosage: 50 MG; QOW; INTH. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYTARABINE, MITOXANTRONE. Patient recovered.

Tysabri Side Effects Report #5725763-4
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on Apr 15, 2008. Female patient, 48 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, balance disorder, cerebellar atrophy, headache, hepatic steatosis, hepatomegaly, hypertensive heart disease, oedema, . TYSABRI dosage: 300 MG; QM; IV. Patient died on 12/15/2007.

Carbamazepine Side Effects Report #5354629-7
CARBAMAZEPINE problem was reported by a Consumer or non-health professional from JAPAN on May 30, 2007. Female patient, 63 years of age, was treated with CARBAMAZEPINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete, atrioventricular block second degree, cerebellar atrophy, cerebral calcification, dyspnoea exertional, . CARBAMAZEPINE dosage: 100 MG BID. Patient recovered.

Sinemet Side Effects Report #5321825-4
Health Professional from UNITED STATES reported SINEMET problem on May 09, 2007. Female patient, 77 years of age, was diagnosed with parkinson's disease and was treated with SINEMET. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, bundle branch block left, cerebellar atrophy, constipation, contusion, depression, dyskinesia, fall, hyporeflexia, . SINEMET dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, BENZOCAINE, ETHOPROPAZINE, ZOPICLONE. Patient was hospitalized. Patient died.

Sinemet Side Effects Report #5321827-8
SINEMET problem was reported by a Health Professional from UNITED STATES on May 09, 2007. Female patient, 77 years of age, was diagnosed with parkinson's disease and was treated with SINEMET. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, bundle branch block left, cerebellar atrophy, constipation, contusion, depression, dyskinesia, fall, hyporeflexia, . SINEMET dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, BENZOCAINE, ETHOPROPAZINE, ZOPLICONE. Patient died.

Lithium Side Effects Report #5259657-8
Physician from UNITED STATES reported LITHIUM CARBONATE problem on Feb 21, 2007. Female patient, 52 years of age, was diagnosed with depression and was treated with LITHIUM CARBONATE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased, cerebellar atrophy, cerebellar syndrome, encephalopathy, haemodialysis, insomnia, therapeutic agent toxicity, . LITHIUM CARBONATE dosage: unknown. Patient was hospitalized. Patient recovered.